Vol 6 , Issue 3 , July - September 2018 | Pages: 1-5 | Research Paper
Received: August 18, 2018 | Revised: August 28, 2018 | Accepted: September 02, 2018 | Published Online: September 15, 2018
Author Details
( * ) denotes Corresponding author
Cardiovascular disease are non-communicable that has become a serious health problem worldwide. The aim of the study was to evaluate the safety and efficacy of a novel herbal liquid formulation “DELSTROK®”. The toxicity study was performed to evaluate the oral acute toxicity of DELSTROK® in rats and to identify the Thrombolytic efficacious dose of DELSTROK®. The toxicity study was carried out at different doses and it was concluded that the LD50 value for DELSTROK® was more than 2000 mg/kg. The efficacy study was carried out and from this study it was concluded that the thrombolytic effect of DELSTROK® is comparable to the commercially thrombolyte, streptokinase. Thus, in this study the LD50 for DELSTROK® was obtained and also DELSTROK® was found to show thrombolytic effect. found to show thrombolytic effect.
Keywords
Delstrok; Herbal Formulation; Thrombolytic; Oral Toxicity; Cardiovascular Diseases.